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Abstract 
Pap smear testing continues to be the single most effective tool in reducing deaths due to cervical cancer 
(Watkins, Gabali, Winkleby, Gaona & Lebaron, 2002). Despite the creation of a national cervical cancer 
screening program, more than 4,000 women die every year in Mexico from this disease. This study 
explored the knowledge, attitudes, and behaviors of Mexican women regarding cervical cancer screening, 
and identified beliefs and barriers that may influence cervical health. All analyses compared women who 
had ever had a Pap test in their lives (“ever”) with women who had never had a Pap test (“never”). In 
bivariate analyses, the following variables were significantly associated (p<0.05) with ever having a Pap 
test at least once in their life: being given information on Pap test by their doctor, number of pregnancies, 
knowing someone who has been diagnosed with cervical cancer, education level, age, and type of 
healthcare facility used most often. The surprisingly high rate of ever screening in this sample (85%) was 
an unexpected finding in this study. More research is needed in order to understand the cultural beliefs 
and screening behaviors of this unique population. Future interventions must address the barriers cited by 
the women in our sample by tailoring interventions specifically to Mexican women and their belief 
system. 
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Introduction 
Cervical cancer is the second most common 
cancer among females in the world and the most 
common in developing countries (Lazcano-
Ponce et al., 1999). The total number of deaths 
worldwide is 235,000 annually. The highest 
rates have been reported in Central America and 
Mexico (Lazcano-Ponce et al., 2001). Secondary 
prevention, achieved through Pap smear testing, 
is the single most effective tool in reducing 
deaths due to cervical cancer (Watkins, Gabali, 
Winkleby, Gaona, & Lebaron, 2002). Despite 
the creation of a national cervical cancer 
screening program, more than 4,000 women die 
every year in Mexico from this disease. Even 
though cervical cancer has historically been one 
of the most treatable cancers, it continues to be a 
major public health concern which results in a 
death every 2 hours in Mexico alone (Hernadez-
Avila, Lazcano-Ponce, DeRuiz, & Romieu, 
1998). Specifically, in 2002, the mortality rate in 
Mexico was 16.9 per 100,000. That same year, 
the mortality rate in Ciudad Juarez was 27.7 per 
100,000. However, rates have decreased over the 
years and are highest in the southern states of 
Veracruz, Morelos, Oaxaca, Chiapas, 
Campeche, and Yucatan (Panorama 
Epidemiologico, 1998-2002). 
 
Background and Public Health Significance 
A critical way to prevent cervical cancer is to 
have Pap tests to detect cervical cell changes. 
Most invasive cervical cancers are found in 
women who have not had regular Pap smears. 
Half of women diagnosed with cervical cancer 
are between the ages of 35-55 (American Cancer 
Society, 2004) .Watkins and associates (2002) 
state that between 20-60% of all cervical cancer 
deaths could be avoided by improving screening 
programs. 
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In most industrialized countries, mortality rates 
from cervical cancer have decreased markedly 
through early detection programs that stress the 
use of Pap tests (Lazcano-Ponce et al., 1999). 
However, in Mexico, it is estimated that over 
62,000 deaths from cervical cancer have 
occurred in the past 15 years. Cervical cancer 
continues to be the leading cancer killer among 
women over the age of 35 (Agurto, Bishop, 
Sanchez, Betancourt & Robles, 2004).The state 
of Nayarit has the highest cervical cancer 
incidence rates in the country (Agurto, Bishop, 
Sanchez, Betancourt, & Robles, 2004). This is 
despite the fact that a cervical cancer screening 
program (CCSP) has been in place since 1974. 
 
The Health Ministry of Mexico regulates the 
CCSP within the National Health System. The 
Pap test is offered to women in each of the 32 
states of the Mexican republic. In Mexico, the 
guidelines (as of 1996) recommend one Pap test 
per year for women after they have become 
sexually active, and do not establish an upper 
age limit (Lazcano-Ponce, Moss, de Ruiz, 
Castro, Hernandez-Avila, 1999). The cervical 
cancer mortality rate for Mexico is 14.7 per 
100,000 women (Hernandez-Avila, Lazcano-
Ponce, De Ruiz & Romieu, 1998), the highest in 
the world, compared to a mortality rate of 3.7 
per 100,000 for Hispanics in the U.S. (American 
Cancer Society, 2003). In Chihuahua, the 
mortality rate associated with cervical cancer is 
8.3 per 100,000 women (Chihuahua state 
government, 2002). 
 
Reasons cited in the literature for low rates of 
Pap testing include low education, low 
acculturation, lower cognitive scores, and other 
demographic, social and psychological factors 
(Wu, Black, & Markides, 2001). Factors 
associated with low effectiveness of screening in 
Mexico are quality and coverage (Lazcano-
Ponce et al., 1999). For example, the quality of 
the actual sample is often deficient and the false 
negative rate for Pap smears is between 10 and 
54%. In addition, coverage is low, with about 
64.2% of women in Mexico City having a 
history of Pap. This is in stark contrast to the 
30% of women in rural areas that have a history 
of Pap (Lazcano-Ponce et al., 1999). Factors 
related to cervical cancer mortality include lack 
of formal education, low socioeconomic level, 
unemployment, rural residence, and insufficient 
access to healthcare (Palacio-Mejia, Rangel-
Gomez, Hernandez-Avila, & Lazcano-Ponce, 
2003). 
 
There is a clear need to delve deeper and explore 
the underlying beliefs and attitudes of Mexican 
women that are leading to such low rates of 
cervical cancer screening, even with the 
existence of a national screening program. 
Further exploratory research may add to the 
knowledge base and contribute to current 
prevention efforts, with the overall goal of 
decreasing mortality rates from cervical cancer. 
It is important to take into account the beliefs, 
barriers and expectations of the women at risk in 
order to understand more about the factors 
associated with low screening rates. Only then 
can appropriate interventions be developed.  
 
Most literature has focused on screening rates 
and factors related to low screening rates in 
other parts of Mexico, mainly rural areas. Not 
much has been researched about the city of 
Juarez, Chihuahua, which boasts a population of 
1.2 million, most of whom have no formal 
education (Mexico Census, 2000). In addition, 
the maquiladora businesses in Juarez lure 
hundreds of young women from other areas of 
Latin America each month (Landau, 2002). 
Maquiladoras are assembly-oriented 
manufacturing plants that are generally foreign-
owned (Hernandez, 2004). These foreign 
industries offset the high cost of labor in their 
own countries by hiring cheaper labor in 
countries like Mexico (Verghese, 2004). The 
fact that these factories permeate Mexican 
economics and employ such a large number of 
women presents a favorable opportunity to learn 
more about their beliefs, attitudes, and barriers 
regarding cervical cancer screening in order to 
respond with appropriate interventions and 
ultimately reduce Mexico’s mortality rate due to 
low screening rates. 
 
Methods 
Study Design and Study Population 
The study population was women over the age 
of 18, who currently reside in Cd. Juarez, 
Mexico. This population yielded a random 
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sample by utilizing Geographic Information 
Systems (GIS) technology to randomly select 
block groups from which to sample women. We 
chose 10 houses from each of 15 randomly 
selected block groups out of the 461 block 
groups identifiable with colonias. Interviewers 
went door-to-door, starting in the middle, until 
they found 10 women in each block group (150 
women) willing to participate. Selecting block 
groups as opposed to streets addressed the issue 
of excluding homes on streets with no names. 
 
All women over the age of 18, who currently 
reside in Ciudad Juarez, were eligible to take 
part in the study. No men and women under 18 
were allowed to participate in this study. 
 
Data Collection Instrument and 
Procedures 
The survey instrument was based on a variety of 
theories and models, most notably the Health 
Belief Model (HBM) and the Theory of Planned 
Behavior (TPB). Survey questions were based 
upon the following constructs: perceived 
susceptibility, perceived seriousness, perceived 
benefits, perceived barriers, self-efficacy, 
attitudes, subjective norms, perceived behavioral 
control, and intention. 
 
Interviewers were trained promotoras employed 
by FEMAP. Each interviewer approached each 
house in the chosen block group and asked to 
speak to a woman in that house over 18 years of 
age. If there was more than one woman over 18 
in a home, the woman with the latest birthday 
was asked to participate. Selection in each block 
group continued until 10 women had been 
interviewed. 
 
Given the low literacy levels in the area, 
interviewers asked the survey questions 
verbally, in Spanish. All participants were asked 
to sign a consent form before they were 
interviewed. Each woman was given a $10 gift 
certificate after the interview was completed, as 
a token of appreciation for her time and 
cooperation.  
 
The survey contained questions on knowledge, 
attitudes and behaviors regarding cervical cancer 
screening. In addition, the survey elicited 
responses about belief systems and barriers that 
may influence cervical health among Mexican 
women. Questions to determine frequency of 
Pap smears and history of screening were also 
included in the survey. 
 
Data were entered into and analyzed using the 
SPSS database program version 10.1.0. 
Independent variables in this study consisted of 
demographic variables and Health Belief Model 
(HBM) construct scale scores, including 
perceived susceptibility, perceived severity, 
benefits, barriers, and self-efficacy. Theory of 
Planned Behavior (TPB) constructs (behavioral 
intention, attitudes, subjective norm, and 
perceived behavioral control) also served as 
independent variables. For example, one barrier 
measure was “It is too expensive to have a Pap 
test”. An example of a subjective norm measure 
was “My husband or partner thinks I should 
have regular Pap tests”. Responses used Likert-
type scaling, ranging from 1 (strongly agree) to 
5 (strongly disagree).  Scores were obtained by 
summing responses to each statement on the 
scale. 
 
The outcome of interest was whether a study 
participant reported having had at least one Pap 
smear, which was treated as a dichotomous 
variable (yes/no). 
 
Data Analysis 
Researchers computed descriptive statistics 
including frequencies and means and standard 
deviations for discrete and continuous study 
variables, respectively. Cronbach’s alpha 
coefficient was computed to test internal 
consistency reliability of the HBM construct 
scales. 
 
This study was based on a cross-sectional design 
and the objective of the data analysis was to test 
the association of demographic characteristics 
and certain theoretical constructs on Pap smear 
utilization. 
 
Bivariate tables were used to summarize the 
association of independent and dependent 
variables. Fisher’s exact test was computed for 
each of the discrete predictor measures since 
contingency table cells frequently contained 
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fewer than five responses. We compared those 
women who had never had a Pap smear to those 
who had ever had a Pap smear, for all variables 
(demographic, HBM constructs, and TPB 
constructs). 
 
Results 
The final sample consisted of 150 females 
between the ages of 18 and 74. Appendix A 
summarizes characteristics of the study 
participants. Overall, 84.7% had ever had a Pap 
test and 68.7% reported having some kind of 
health care coverage, including private 
insurance, Seguro Social, ISSTE, or other health 
coverage. The majority (69.3%) were currently 
married and almost half (48.3%) of the 
participants had a monthly household income of 
less than 2000 pesos (approx. 180 US dollars). 
In addition, only 14% reported having 
completed high school. Approximately 75% of 
the sample had ever been given information on 
the Pap test from their healthcare provider. 
 
Cronbach’s alpha coefficients were computed to 
test internal consistency reliability of the HBM 
construct scales. The benefits, barriers, and self-
efficacy subscales indicated reliable alphas of 
0.76. The subjective norm scale produced a 
Cronbach’s alpha of 0.71. The susceptibility and 
severity alphas were a bit smaller, indicating less 
reliable scales (susceptibility= 0.44, severity= 
0.595). 
 
All analyses compared women who had ever had 
a Pap test in their lives (“ever”) with women 
who had never had a Pap test (“never”). In 
bivariate analyses, the following variables were 
significantly associated (p<0.05) with ever 
having a Pap test at least once in their life: being 
given information on Pap test by their doctor, 
number of pregnancies, knowing someone who 
has been diagnosed with cervical cancer, 
education level, age, and type of healthcare 
facility used most often. 
 
Regarding age, the majority (55.1%) of the 
women who had ever received a Pap test were 
36 years or older. Those who had never had a 
Pap test were more likely to be in the “less than 
25 yrs” age group. Those women who had 
experienced more pregnancies were more likely 
to have ever had a Pap test (p=0.002). Regarding 
healthcare access, those women who had ever 
had a Pap test were more likely to use the 
Instituto Mexicano del Seguro Social (IMSS) 
clinic most often, whereas the women who had 
never had a Pap test were more likely to use a 
doctor’s office for healthcare services. 
Interestingly, when considering education level, 
the women who reported having had a Pap test 
were more likely to have completed up to 
elementary school, while those in the “never” 
group were more likely to have completed up to 
middle school.  
 
Of those who had never had a Pap test or who 
hadn’t had one in more than three years, the 
most important reasons for not doing so were 
never thinking about it, not having any 
problems, and putting it off. Conversely, of 
those who had ever had a Pap, the most cited 
reasons that encouraged them were a reminder 
from the doctor, an ad on TV, and self-referral. 
 
Perceived susceptibility responses were 
compared across both outcome groups (“ever” 
vs. “never”). Overall, those in the “never” group 
had higher susceptibility scores than the “ever” 
group. That is, a larger percentage of the “never” 
group either agreed or strongly agreed with the 
positive statements about susceptibility. 
However, when comparing responses on 
individual susceptibility items, a full 65.2% of 
those in the “never” category either agreed or 
strongly agreed that compared to other women, 
they are at a lower risk for cervical cancer, as 
compared to 59.5% of those in the “ever” 
category (p=0.04).  
 
When it came to perceived severity, both groups 
equally agreed that there are effective treatments 
for cervical cancer and that cervical cancer is not 
as serious as other types of cancers. However, 
twice as many women in the “ever” group 
believed that cervical cancer is easily cured, 
although this result was not statistically 
significant. 
 
There was a significant association between 
believing a Pap test can be done quickly and 
ever having had a Pap test (p<0.001). Of those 
women who agreed with this statement, 93.7% 
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had ever had a Pap test, as compared to 63.7% in 
the “never” group. This suggests that perhaps 
those women who had never had a Pap test 
believe it takes too much time, thus creating a 
barrier for them.  
 
None of the questions assessing subjective norm 
proved to be statistically significant, although 
there was a trend towards significance regarding 
the item “I try to do what my doctor thinks I 
should do” (p=0.056). The overall findings 
suggest that, for these women, subjective norm 
is not a very good predictor of ever having had a 
Pap test. That is, they do not seem to perceive 
social pressure to perform or not perform the 
behavior (getting a Pap test). 
 
Of the women in our sample, those who had 
ever had a Pap test were more likely than those 
who had not to say they felt very sure or 
completely sure they could have a discussion 
with their healthcare provider regarding the test 
(82.4% vs. 78%), they could get a Pap test even 
if they were worried that it will be painful (74% 
vs. 57%), and that they could get a Pap test even 
if they were worried that it would be 
embarrassing (49.6% vs. 22%). In contrast, 
those who had never had a Pap test were more 
likely than those who had to say they felt sure or 
completely sure that they could make an 
appointment to have a Pap test (87% vs. 84%) 
and that they would be able to reschedule if an 
appointment were missed (95.5% vs. 90%), 
which was the only statistically significant 
finding (p=0.031). 
 
Perceived barriers were also assessed with this 
sample. When comparing responses between the 
women who had had the Pap test and those who 
had not, three of the items proved to be 
statistically significant: Pap test being painful 
(p<0.001), Pap test being too expensive 
(p=0.009), and not knowing where to go for a 
Pap test (p=0.048). In addition, when comparing 
women who had ever had a Pap test with those 
who had never had a Pap test, more women in 
the latter group cited the following barriers: 
worry, painful test, being examined by a male 
provider, fear of test results, embarrassment, not 
knowing where to go for a Pap test, assumptions 
that the woman is having sex, not believing it is 
important for a woman their age, and distrust of 
labs that assess the tests. Only two of these 
differed significantly: fearing a painful test and 
not knowing where to go for a Pap test 
(Appendix B).  
 
Discussion 
The surprisingly high rate of ever screening in 
this sample (85%) was an unexpected finding in 
this study. Compared to one study by Byrd 
(2004), this rate is high. Byrd found that 69% of 
Hispanic women along the U.S.-Mexico border 
had ever had a Pap test. In addition, more 
women in that study agreed with the barrier 
statements and the agreement with barriers 
statements was more often associated with never 
having had a Pap test. However, it is worth 
noting that the women in that study were 
restricted to 18-25 years of age. 
 
Our results are not consistent with findings from 
other studies done in Mexico. A study in Mexico 
City showed that only 64.2% of women had a 
history of Pap test; that number is even lower in 
rural areas (Lazcano-Ponce, Moss, de Rufz, 
Castro & Avila, 1999). The lower prevalence of 
screening in younger women in our study is 
consistent with a study by Lazcano-Ponce et al. 
(2002). 
 
Federacion Mexicana de Asociaciones Privadas 
(FEMAP) foundation, the Mexican entity we 
worked with in this study was recently funded 
by the Paso del Norte Health Foundation to 
deliver cancer screening tests to the population 
they serve.  Their outreach into the communities 
may explain this relatively high rate of 
screening. This foundation’s mission is to raise 
the quality of life among people living in 
poverty in Mexico, through a variety of health, 
economic, and social services. The foundation is 
equally committed to improving conditions on 
both sides of the border, through the support of 
many programs. Through a Family Hospital, 
they have helped to build sustainable health 
programs, which focus on disease prevention, 
immunization campaigns, family planning, drug 
and alcohol-abuse prevention, and HIV/AIDS 
prevention. It is possible that the foundation has 
already raised awareness of the need for testing 
in the majority of communities in Ciudad Juarez. 
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Overall, the women in our study understood 
their susceptibility to and the severity of cervical 
cancer. Those who had never had a Pap test 
perceived themselves to be less susceptible (at a 
lower risk for cervical cancer) than other women 
their age. This is consistent with the Health 
Belief Model and its hypothesis that actors feel 
more susceptible than non-actors do. 
 
The women overwhelmingly agreed that 
numerous benefits exist to screening. They 
agreed that regular Pap tests would give them 
peace of mind, find a problem before it develops 
into cancer, are necessary even if there is no 
family history or cancer, and are very accurate 
tests for cancer. 
 
A notable percentage of women in our study 
(32%) agreed that being examined by a male 
provider would discourage them from getting a 
Pap test, which is also important when 
considering what could be done to reduce these 
barriers. In addition, 36% agreed that if a 
woman has not had sex, a Pap test will take 
away her virginity, which points to the need for 
correcting misperceptions about the Pap test.  
Similarly, 38% agreed that if a young, unmarried 
woman goes for a Pap test, everyone will 
assume she is having sex. Being worried about 
the test and feeling embarrassed appear to be 
valid barriers to screening and should also be 
addressed in future interventions. 
 
Overall, the majority of the women agreed that 
their husbands think they should have regular 
Pap tests; however, fewer women agree that they 
try to do what their partner wants them to do. In 
contrast, almost all of the women try to do what 
the doctor thinks they should do. A full 89% of 
the women reported that they planned to have a 
Pap test in the next six months, which is very 
promising. Self-efficacy did not appear to be a 
contributing factor in getting a Pap test. Both 
groups appeared to feel confident that they could 
perform the behavior. 
 
When looking at differences between both 
comparison groups (ever had a Pap test vs. never 
had a Pap test), women who had never had a Pap 
test were more likely to use a private doctor’s 
office, as opposed to women who had ever had a 
Pap test, who were more likely to use the IMSS 
clinic (Mexican social security system). One 
possible reason for this is that those using 
private doctors may be receiving care less often 
if they have to pay for care, and so they may not 
be exposed to the messages or are not being 
encouraged to be screened. The results 
corroborate this, as one of the variables that was 
significantly associated with ever having a Pap 
test was being given information on the Pap test 
by a doctor. This demonstrates the grave need 
for the physician to be active in communicating 
to women the importance of the Pap test. 
 
There was not much difference between groups 
in perceived benefits other than the quickness of 
the test, which the women in the “never” group 
did not perceive as a benefit. However, this may 
be a result of them never actually having gone 
through the test so they do not have an accurate 
perception of how long it actually takes. 
 
When considering subjective norm, nothing 
seemed to be close to significance except for the 
item that assessed whether women do what the 
doctor thinks they should do. Once again, this 
demonstrates that the doctor is an important 
vehicle for information exchange. Previous 
literature cited negative social pressure from 
male partners (Lazcano-Ponce et al., 1999) as a 
barrier to screening; however, we did not find 
this in our study. When comparing groups on 
self-efficacy measures, significantly more 
women in the “ever” group reported being more 
sure that they could find time in their schedule 
for the appointment. 
 
The fact that the barrier “Pap test is painful” 
remained significant in further analyses speaks 
to its importance. Access to healthcare and 
issues of cost also seemed to be notable barriers 
for many women. However, this might be an 
indicator that many women are not aware that 
the national screening program provides free or 
very low-cost Pap tests to all Mexican women. 
 
This study yielded barriers that have also proven 
significant in previous studies, including access 
(Agurto, Bishop, Sanchez, Betancourt & Robles, 
2004); cost and not being told of the test by their 
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doctor (Fernandez-Esquer, Espinoza, Torres, 
Ramirez & McAlister, 2003); pain and 
embarrassment (Lazcano-Ponce et al. 1999); and 
education level (Lazcano-Ponce et al. 2002). 
 
Other barriers that have been cited in the 
literature which were not found to be significant 
in this study include fear of results (Agurto, 
Bishop, Sanchez, Betancourt & Robles, 2004), 
fatalism, opposition by male partner, and being 
examined by male providers (Lazcano-Ponce et 
al. 1999). 
 
Strengths 
The paucity of research in this area and with this 
population indicates a need for further research. 
This study serves as an impetus for future 
researchers to replicate the study with a larger 
sample size, thus adding to the knowledge base 
and bringing us a step closer to understanding 
screening practices and barriers to screening in 
this population. Interventions could easily be 
developed using the findings of the study. Pre-
testing the instrument with this smaller sample 
of women enables researchers to make 
improvements to the study design and research 
process, thereby improving the internal validity 
of the study. 
 
Limitations 
The high rate of screening found in this study 
may very well be because some of the women in 
our sample may not have felt comfortable 
reporting such sensitive material to the lay 
health workers that visited their homes, thus 
introducing self-report bias. Perhaps they were 
hesitant to disclose this personal information to 
the interviewers, some of which had become 
close friends by means of other work they had 
done in the community. Lack of training may 
also have contributed to the interviewers not 
administering the survey correctly, thus 
compromising the validity of the results. 
 
Conclusions & Recommendations 
Cervical cancer continues to be a major public 
health problem in Mexico, despite the national 
screening program that has been in existence 
since 1974. Current screening guidelines are 
ambiguous at best. An annual Pap test is 
recommended for women after they have begun 
sexual relations, but there is no age limit 
(Lazcano-Ponce et al., 1998). Numerous studies 
have documented the lack of effectiveness of the 
program and attributed its suboptimal success to 
factors associated with quality of care and 
coverage (Lazcano et al., 2002). Perhaps 
coverage could be improved by raising 
awareness of the program and its benefits, 
including the free services. The high rate of 
screening in our study is hopeful, as it may be a 
sign of already increased coverage of the 
program in Juarez. 
 
More research is needed in order to understand 
the cultural beliefs and screening behaviors of 
this unique population. It is important to target 
younger females when developing future 
interventions, as women younger than 25 years 
old were less likely to have had a Pap test. In 
addition, it would be wise to develop 
interventions to raise awareness, involve 
doctors, and place more ads on television, 
perhaps during Mexican telenovelas (soap 
operas). 
 
It is also evident that doctors must play a more 
active role in disseminating information and 
advising their female patients to undergo the Pap 
test. According to Austin, Ahmad, McNally, and 
Stewart (2002), physician recommendation is 
one of the most important cues to action. There 
is a greater need for better communication 
between the provider and the patient, 
particularly because if the doctor is the 
persuader of the recommendation, the likelihood 
of accepting the importance of this screening is 
increased. Physicians and healthcare personnel 
alike must work to reduce the anxiety of women 
concerning their worries about painful test and 
embarrassment if we are to begin to work 
toward the ultimate goal of increased screening. 
 
Future interventions must address the barriers 
cited by the women in our sample by tailoring 
interventions specifically to Mexican women 
and their belief systems. In addition, given that 
barriers proved to be important determinants of 
screening with this sample, perhaps they could 
be explored further by means of qualitative 
research, including focus groups and direct 
interviews. This would enable us to corroborate 
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the findings of the current study, and work 
towards planning successful interventions 
specifically tailored to this population, while 
contributing to the knowledge base. 
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Appendix A 
Demographic and health characteristics of the study population, by history of Pap test. 
 
Characteristic Total (%) 
N=150 
Ever (%) 
N=127 
Never (%) 
N=23 
p-value 
Highest educational level attained 
 Elementary School 
 Middle School 
 High School 
 More than High School 
 
44.0 
32.0 
14.0 
10.0 
 
52.8 
30.6 
16.7 
9.3 
 
28.6 
61.9 
9.5 
0.7 
0.028 
Has health care coverage 
 Yes 
 No 
 
68.7 
30.0 
 
72.4 
26.0 
 
47.8 
52.2 
0.051 
Ever had Pap test 
 Yes 
 No 
 
84.7 
15.3 
 
-- 
-- 
 
-- 
-- 
 
Perception of current health status 
 Excellent 
 Very Good 
 Good 
 Fair 
 Poor 
 
2.7 
11.3 
32.7 
49.3 
4.0 
 
3.1 
9.4 
34.6 
48.8 
3.9 
 
0.0 
21.7 
21.7 
52.2 
4.3 
0.367 
Ever been pregnant 
 Yes 
 No 
 
94.0 
6.0 
 
94.5 
5.5 
 
91.3 
8.7 
0.628 
Ever heard of cervical cancer 
 Yes 
 No 
 
91.3 
8.7 
 
92.1 
7.9 
 
87.0 
13.0 
0.422 
Marital Status 
 Never married 
 Married 
 Separated 
 Divorced 
 Widowed 
 
13.3 
69.3 
9.3 
2.7 
4.7 
 
14.2 
67.7 
8.7 
3.1 
5.5 
 
8.7 
78.3 
13.0 
0.0 
0.0 
0.759 
Last month’s household income 
 Less than 2000 pesos 
 Between 2000 and 4000 pesos 
 More than 4000 pesos 
 
48.3 
38.3 
13.3 
 
49.5 
35.6 
14.9 
 
42.1 
52.6 
5.3 
0.301 
Age group 
 Less than 25 yrs 
 25-35 yrs 
 36-45 yrs 
 46+ 
 
17.3 
32.7 
28.0 
22.0 
 
11.8 
33.1 
30.7 
24.4 
 
47.8 
30.4 
13.0 
8.7 
0.001 
Ever smoked cigarettes 
 Yes 
 No 
 
44.7 
55.3 
 
44.1 
55.9 
 
47.8 
52.2 
0.821 
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Appendix B 
Description of Perceived Barriers responses and comparison across “Ever had Pap smear” 
and “Never had Pap smear” via Fisher’s Exact Test. 
 
Perceived Barriers Ever (%) 
N=127 
Never (%) 
N=23 
p-value 
Getting a Pap test would only make me worry. 
 Strongly agree 
 Agree 
 Undecided 
 Disagree 
 Strongly disagree 
 
2.4 
13.4 
7.1 
72.4 
4.7 
 
8.7 
17.4 
17.4 
52.2 
4.3 
0.117 
The Pap test is painful. 
 Strongly agree 
 Agree 
 Undecided 
 Disagree 
 Strongly disagree 
 
2.4 
8.7 
3.2 
77.8 
7.9 
 
0.0 
17.4 
34.8 
39.1 
8.7 
0.000 
It is too expensive to have a Pap test. 
 Strongly agree 
 Agree 
 Undecided 
 Disagree 
 Strongly disagree 
 
0.8 
9.4 
3.1 
78.0 
8.7 
 
0.0 
0.0 
21.7 
65.2 
13.0 
0.009 
Being examined by a male provider would discourage me 
from getting a Pap test. 
 Strongly agree 
 Agree 
 Undecided 
 Disagree 
 Strongly disagree 
 
 
7.9 
23.0 
3.2 
77.1 
8.7 
 
 
13.0 
21.7 
0.0 
56.5 
8.7 
0.931 
If I don’t have any discomfort or pain, I don’t need a Pap 
test. 
 Strongly agree 
 Agree 
 Undecided 
 Disagree 
 Strongly disagree 
 
 
13.4 
14.2 
0.8 
66.1 
5.5 
 
 
4.3 
17.4 
4.3 
65.2 
8.7 
0.350 
I would not get a Pap test because of fear of test results. 
 Strongly agree 
 Agree 
 Undecided 
 Disagree 
 Strongly disagree 
 
3.1 
4.7 
2.4 
83.5 
6.3 
 
4.3 
13.0 
0.0 
73.9 
8.7 
0.367 
It is too embarrassing to have a Pap test. 
 Strongly agree 
 Agree 
 Undecided 
 Disagree 
 Strongly disagree 
 
3.1 
18.9 
4.7 
65.4 
7.9 
 
4.3 
21.7 
4.3 
65.2 
4.3 
0.953 
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Perceived Barriers Ever (%) 
N=127 
Never (%) 
N=23 
p-value 
If a woman has not had sex, a Pap test will take away her 
virginity. 
 Strongly agree 
 Agree 
 Undecided 
 Disagree 
 Strongly disagree 
 
 
12.7 
25.4 
18.3 
38.9 
4.8 
 
 
14.3 
17.4 
17.4 
56.5 
4.3 
0.568 
I don’t know where I could go if I wanted a Pap test. 
 Strongly agree 
 Agree 
 Undecided 
 Disagree 
 Strongly disagree 
 
9.4 
7.1 
2.4 
73.2 
7.9 
 
13.0 
26.1 
4.3 
52.2 
4.3 
0.048 
My partner would not want me to have a Pap test. 
 Strongly agree 
 Agree 
 Undecided 
 Disagree 
 Strongly disagree 
 
8.7 
10.3 
4.0 
68.3 
8.7 
 
13.0 
4.3 
4.3 
73.9 
4.3 
0.815 
If a young, unmarried woman goes for a Pap test, 
everyone will assume she is having sex. 
 Strongly agree 
 Agree 
 Undecided 
 Disagree 
 
 
11.8 
26.0 
11.8 
45.7 
 
 
4.3 
34.8 
8.7 
52.2 
0.726 
A Pap test is not important for a woman my age. 
 Strongly agree 
 Agree 
 Undecided 
 Disagree 
 Strongly disagree 
 
14.2 
9.4 
1.6 
65.4 
9.4 
 
21.7 
13.0 
4.3 
52.2 
8.7 
0.489 
Pap test results cannot be trusted because some labs do 
the test better than others. 
 Strongly agree 
 Agree 
 Undecided 
 Disagree 
 Strongly disagree 
 
 
8.7 
6.7 
11.9 
55.6 
7.1 
 
 
4.3 
21.7 
8.7 
52.2 
13.0 
0.767 
I worry that if have a Pap test, I will need an operation. 
 Strongly agree 
 Agree 
 Undecided 
 Disagree 
 Strongly disagree 
 
2.4 
29.9 
7.1 
55.1 
5.5 
 
0.0 
13.0 
21.7 
56.5 
8.7 
0.111 
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